Li Hong-Wu, Tang Shi-Lei
General Surgery Department, The Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning Province, China, 110032.
J Cancer. 2021 Oct 17;12(23):7111-7119. doi: 10.7150/jca.60379. eCollection 2021.
Gastrointestinal malignant tumor is the fourth most common cancer in the world and the second cause of cancer death. Due to the susceptibility to lymphatic metastasis and liver metastasis, the prognosis of advanced tumor patients is still poor till now. With the development of tumor molecular biology, the tumor microenvironment and the cytokines, which are closely related to the proliferation, infiltration and metastasis, have become a research hotspot in life sciences. Colony stimulating factor-1 (CSF-1), a polypeptide chain cytokine, and its receptor CSF-1R are reported to play important roles in regulating tumor-associated macrophages in tumor microenvironment and participating in the occurrence and development in diversities of cancers. Targeted inhibition of the CSF-1/CSF-1R signal axis has broad application prospects in cancer immunotherapy. Here, we reviewed the biological characters of CSF-1/CSF-1R and their relationship with gastrointestinal malignancies.
胃肠道恶性肿瘤是全球第四大常见癌症,也是癌症死亡的第二大原因。由于易发生淋巴转移和肝转移,晚期肿瘤患者的预后至今仍然很差。随着肿瘤分子生物学的发展,与肿瘤增殖、浸润和转移密切相关的肿瘤微环境和细胞因子已成为生命科学领域的研究热点。据报道,集落刺激因子-1(CSF-1),一种多肽链细胞因子,及其受体CSF-1R在调节肿瘤微环境中的肿瘤相关巨噬细胞以及参与多种癌症的发生发展中发挥着重要作用。靶向抑制CSF-1/CSF-1R信号轴在癌症免疫治疗中具有广阔的应用前景。在此,我们综述了CSF-1/CSF-1R的生物学特性及其与胃肠道恶性肿瘤的关系。